about
Advances in sarcoma diagnostics and treatmentEpigenetics in normal and malignant hematopoiesis: An overview and update 2017.Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma.Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2.Therapeutic targeting using tumor specific peptides inhibits long non-coding RNA HOTAIR activity in ovarian and breast cancer.CBX7 is a glioma prognostic marker and induces G1/S arrest via the silencing of CCNE1.Ezh2 Acts as a Tumor Suppressor in Kras-driven Lung Adenocarcinoma.Transcriptomic analyses of RNA-binding proteins reveal eIF3c promotes cell proliferation in hepatocellular carcinoma.The Effect of Sodium Valproate on the Glioblastoma U87 Cell Line Tumor Development on the Chicken Embryo Chorioallantoic Membrane and on EZH2 and p53 Expression.EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion.Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid TumorsRole of EZH2 in cancer stem cells: from biological insight to a therapeutic target.Non-Canonical EZH2 Transcriptionally Activates RelB in Triple Negative Breast CancerAberrant expression of ALK and EZH2 in Merkel cell carcinomaGenomic and Epigenomic Alterations in CancerMarginal zone lymphoma-derived interfollicular diffuse large B-cell lymphoma harboring 20q12 chromosomal deletion and missense mutation of BIRC3 gene: a case report.LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2.MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes.From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic CancersGSK3β inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancers.The microRNA signature of patients with sunitinib failure: regulation of UHRF1 pathways by microRNA-101 in renal cell carcinomaTherapeutic Approaches Targeting MYC-Driven Prostate CancerIntegrated bioinformatics analysis of chromatin regulator EZH2 in regulating mRNA and lncRNA expression by ChIP sequencing and RNA sequencing.Blocking EZH2 methylation transferase activity by GSK126 decreases stem cell-like myeloma cells.Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer.Inhibitors of the Histone Methyltransferases EZH2/1 Induce a Potent Antiviral State and Suppress Infection by Diverse Viral Pathogens.EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer metastasis.Expression and inhibition of BRD4, EZH2 and TOP2A in neurofibromas and malignant peripheral nerve sheath tumors.EZH2 is involved in silencing of WNT5A during epithelial-mesenchymal transition of colon cancer cell line.Semi-Quantitative Mass Spectrometry in AML Cells Identifies New Non-Genomic Targets of the EZH2 Methyltransferase.Overview of Transgenic Mouse Models of Myeloproliferative Neoplasms (MPNs).Molecular characterization of EZH2 mutant patients with myelodysplastic/myeloproliferative neoplasms.A New Role for ERα: Silencing via DNA Methylation of Basal, Stem Cell, and EMT Genes.Polycomb repressive complex 2 in an autoinhibited state.DNA methylation of METTL7A gene body regulates its transcriptional level in thyroid cancerEnhancer of Zeste Homolog 2 Inhibition Stimulates Bone Formation and Mitigates Bone Loss Caused by Ovariectomy in Skeletally Mature Mice.Marked for death: targeting epigenetic changes in cancer.Improving understanding of chromatin regulatory proteins and potential implications for drug discovery.Novel therapeutic approaches in chondrosarcoma.Recently discovered EZH2 and EHMT2 (G9a) inhibitors.
P2860
Q28069695-746D50F0-754F-468C-BE13-B381FBC8BA1DQ33607609-3CC9DC38-B167-4633-998D-EDB06476F59FQ33633473-08623C4F-CF4E-4548-856F-58F8F1169042Q33652164-1DE9A1FA-1F2F-4E3E-80DE-4F9BCB334C72Q33678588-E5896B30-8E0B-4D62-A27F-51E08E00FD82Q33688773-1F05096F-B6FF-4672-820E-C75A7EC37DA3Q33717790-1459E2FD-7E71-44A7-A6CD-79743934B2A6Q33738850-BAB0F362-C4C2-43FA-A477-E84D674403B1Q33794860-31609095-30AD-42C3-99AA-C5447847E996Q33804215-D54FA243-A585-4D49-8D9F-9663F5D345A8Q33882326-F995EC81-987E-4533-8079-F2BF8B144184Q33914216-0C6F6C09-BB18-40AF-B2AF-FEE13C927431Q36169303-C0E009F3-4594-4B60-9679-C3C83708A3D7Q36328692-FEECCDB9-1D87-48D3-B12A-E1DE7C7159A3Q37057145-52A449F1-3AF0-461D-9969-459D674C6CEDQ37517553-0DBA0E47-7115-442F-AF51-FF96DA86B441Q37523103-5D942482-3672-49DB-8B1C-A3562B05CDE0Q37604559-6B9D1252-75BB-45DA-BC81-49B47700CBBDQ37631655-C42CCD70-3FE8-4261-B1EB-78020137BB4DQ37636768-B64B8125-50AC-4B09-BD5F-1F698BD4CDB5Q37644821-1E674653-9D7A-4E7B-8476-308005DFDDEDQ37676253-C3013FE9-9E4D-4CCA-BC0B-FC631F35F712Q37697207-86677687-B6FE-4934-A6B0-AF42363DB565Q37709478-79D9D2C4-81B1-4072-853A-72F9C18D6C08Q37736423-7900A963-A6C2-4B0A-B59B-4CE5F849E860Q38156730-9F586C02-1C4C-481E-B34D-6DDCECA7324BQ38651948-8A9AB62E-CAAD-4E45-9727-B4E5E9CF40BCQ38694793-4DBA74D8-CAC9-44CA-9C5C-21B8ABBD1720Q38696296-2BFC7101-A81F-4BFC-9D3A-F287E773D8C7Q38698037-8DDA8CED-E89C-4619-8CDF-521CBE6FF91DQ38699339-12281862-8D76-4128-A7B0-D49378D4F68AQ38699939-87E92B19-43FD-478D-9629-31B21F37EE07Q38720232-FE77855B-92F5-475B-9350-CCA54BFAEE6CQ38728946-5D668E60-62A7-4FB8-9163-C85CDD5F6556Q38729283-9B1CFB46-E762-46D0-8E8A-1833222FC462Q38739722-7EFD7FEF-4339-475C-9833-8557C9857D1AQ38747872-BA26572F-9CA5-42DA-8FC3-2DB9F13D9799Q38753861-BCD023EB-3629-4D3D-AC93-C6F165484837Q38764510-615E20F3-5D76-4961-A6D7-3081911B41F7Q38829039-E4365548-EE8A-44D1-84E0-641581CFAEA8
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Targeting EZH2 in cancer
@ast
Targeting EZH2 in cancer
@en
Targeting EZH2 in cancer
@nl
type
label
Targeting EZH2 in cancer
@ast
Targeting EZH2 in cancer
@en
Targeting EZH2 in cancer
@nl
prefLabel
Targeting EZH2 in cancer
@ast
Targeting EZH2 in cancer
@en
Targeting EZH2 in cancer
@nl
P2860
P3181
P356
P1433
P1476
Targeting EZH2 in cancer
@en
P2093
Kimberly H Kim
P2860
P2888
P304
P3181
P356
10.1038/NM.4036
P407
P577
2016-02-01T00:00:00Z
P6179
1007647669